We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Second-line Therapy (TASER-P)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01788891
Recruitment Status : Completed
First Posted : February 11, 2013
Last Update Posted : May 11, 2016
amfAR, The Foundation for AIDS Research
Dr Cipto Mangunkusumo General Hospital
Pediatric Institute, Hospital Kuala Lumpur
Chiang Mai University
Srinagarind Hospital, Khon Kaen University
Mahidol University
Children's Hospital Number 1, Ho Chi Minh City, Vietnam
Children's Hospital Number 2, Ho Chi Minh City, Vietnam
The Kirby Institute for Infection and Immunity in Society
University of California, San Francisco
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2015
  Study Completion Date : July 2015